Department of Neurosurgery, Functional Radiosurgery and Gamma Knife Unit-IRCCS Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.
Department of Neurosurgery, Functional Radiosurgery and Gamma Knife Unit-IRCCS Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.
World Neurosurg. 2019 Aug;128:562-572. doi: 10.1016/j.wneu.2019.05.058. Epub 2019 May 16.
Metastatic meningiomas (MMs) are rare (0.1 of 100 cases). Their treatment requires a multimodal approach, with surgery, radiotherapy, chemotherapy, and radiosurgery, which allows a long-term local control (LC) and an extension of free survival. In this study, the authors performed a review of the literature and reported 2 cases of patients affected by extracranial MMs, with long-term follow-up.
Case 1: A 48-year-old woman was admitted for resection of an extra-axial falx lesion (meningioma G1). After 2 years, the lesion got a local recurrence, resected with a histologic diagnosis of meningioma G3. During the next 9 years, the patient underwent 5 Gamma Knife radiosurgery (GKRS) procedures for local recurrence. At 56 years, she was readmitted for a surgical local recurrence (histologic definition: anaplastic meningioma G3). At the age of 62, the patient underwent a right lobectomy for a lung mass (histologic diagnosis: anaplastic meningioma G3). After that, multiple lesions at soma L5 and adrenal gland were discovered and then monitored. Case 2: A 48-year-old woman was operated for a lesion involving torcular herophili (meningioma G2). After 3 years, a local recurrence requires GKRS combined with tamoxifen. In the next 7 years, she underwent 5 GKRS procedures for local recurrence. The patient also underwent chemotherapy with octreotide. At the age of 61, she discovered multiple lesions in both lungs, liver, and kidney. A hepatic biopsy showed anaplastic meningioma G3. Also this patient does not suffer from any neurologic or clinical deficits.
LC in malignant meningioma is achievable through a multimodal approach; GKRS makes possible LC, but a novel aspect of these lesions is opened to discussion: the metastases. These reports show that multimodal treatment for MMs is an effective approach with good LC and improvement of overall survival. However, a long survival may allow systemic diffusion of the disease, in particular, when sagittal sinus is involved.
转移性脑膜瘤(MMs)较为罕见(每 100 例中有 0.1 例)。其治疗需要多模式方法,包括手术、放疗、化疗和放射外科手术,以实现长期局部控制(LC)和延长无进展生存期。在本研究中,作者对文献进行了回顾,并报告了 2 例长期随访的颅外 MMs 患者。
病例 1:一名 48 岁女性因切除矢状窦旁镰旁病变(脑膜瘤 G1)而入院。2 年后,病变局部复发,组织学诊断为脑膜瘤 G3。在接下来的 9 年中,患者接受了 5 次伽玛刀放射外科(GKRS)治疗局部复发。56 岁时,因手术局部复发(组织学定义:间变脑膜瘤 G3)再次入院。62 岁时,患者因右侧肺肿块(组织学诊断:间变脑膜瘤 G3)行肺叶切除术。此后,发现并监测了 L5 椎体和肾上腺的多个病变。病例 2:一名 48 岁女性因累及窦汇的病变而行手术治疗(脑膜瘤 G2)。3 年后,局部复发需要 GKRS 联合他莫昔芬治疗。在接下来的 7 年中,她接受了 5 次 GKRS 治疗局部复发。患者还接受了奥曲肽化疗。61 岁时,患者发现双肺、肝脏和肾脏均有多处病变。肝活检显示间变脑膜瘤 G3。该患者也没有任何神经或临床缺陷。
多模式方法可实现恶性脑膜瘤的 LC;GKRS 可实现 LC,但这些病变的一个新方面仍有待讨论:转移。这些报告表明,MM 的多模式治疗是一种有效的方法,可实现良好的 LC 并改善总体生存率。然而,长期生存可能会导致疾病的全身扩散,特别是当矢状窦受累时。